Description
Bevetex 300mg Injection is a targeted therapy used in the treatment of certain types of cancer. Its active ingredient is Bevacizumab, a recombinant humanized monoclonal antibody. Bevacizumab works by inhibiting vascular endothelial growth factor (VEGF), a protein that plays a crucial role in the formation of new blood vessels. Tumors require a blood supply to grow and spread, and by blocking VEGF, Bevetex helps to starve the tumor of nutrients and oxygen, thereby slowing or stopping its growth. It is indicated for the treatment of metastatic colorectal cancer, advanced non-squamous non-small cell lung cancer, recurrent glioblastoma, metastatic renal cell carcinoma, and advanced cervical cancer, often in combination with chemotherapy. The dosage and administration of Bevetex 300mg Injection should be determined by a qualified healthcare professional based on the specific cancer type and stage, as well as the patient’s overall health. Common side effects may include hypertension, proteinuria, fatigue, and gastrointestinal issues. Serious side effects can occur, so it is essential to discuss potential risks with your doctor. Bevetex 300mg Injection should be stored at room temperature and protected from light. Do not freeze.
